| 产品名称 | Peptides EP14587_1 | SARS-CoV SSp-1 A2 (HLA-A*02:01) |
|---|---|
| 目录号 | EP14587_1 |
| 别名 | SARS-CoV SSp-1 A2 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP14587_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP14587_1 | SARS-CoV SSp-1 A2 (HLA-A*02:01)
品名：SARS-CoV SSp-1 A2 (HLA-A*02:01)
货号：EP14587_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
The sequence is related to the HLA-A*0201-restricted coronavirus SARS-CoV spike protein peptide SSp-1. It was demonstrated that SARS-CoV protein-derived peptide-1 (SSp-1 RLNEVAKNL) induces peptide-specific CTLs both in vivo (transgenic mice) and in vitro (human PBLs), which specifically releases interferon-gamma (IFN-gamma) upon stimulation with SSp-1-pulsed autologous dendritic cells (DCs) or T2 cells.
